Mybracin (Dexamethasone, Tobramycin)

Dexamethasone acts as a glucocorticoid receptor agonist, suppressing inflammatory cytokines and stabilising cell membranes. Tobramycin, an aminoglycoside, binds to the bacterial 30S ribosomal subunit, causing misreading of mRNA and halting protein synthesis, which leads to bacterial cell death.

The dosing regimen for Mybracin is determined by the prescribing ophthalmologist based on the specific condition, severity and patient factors. Typical use involves instilling the recommended number of drops into the affected eye(s) as directed on the prescription label.

Safety data for Mybracin in pregnancy and lactation are limited. It should be used only if the potential benefit justifies any possible risk to the fetus or infant, and this decision must be made by the treating eye‑care professional.

To order Mybracin, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mybracin combines a corticosteroid with an aminoglycoside, offering both anti‑inflammatory and antibacterial activity in a single formulation. Compared with single‑agent antibiotics, it reduces the need for multiple drops, but clinicians must consider steroid‑related risks such as intra‑ocular pressure elevation.

Store Mybracin at room temperature, preferably below 25 °C. Keep the vial in its original packaging, protect it from light and moisture, and ensure the cap is tightly closed when not in use.

Mybracin is applied topically to the eye. The patient should wash hands, tilt the head back, pull down the lower eyelid, and instill the prescribed number of drops into the conjunctival sac. The eye should be closed gently for a few seconds to allow absorption.

Serious risks include allergic reactions such as angio‑edema, secondary glaucoma from prolonged steroid exposure, corneal ulceration, and rare systemic toxicity from the aminoglycoside component. Any sudden vision changes, severe pain or swelling should prompt immediate medical attention.

Mybracin should be avoided in patients with known hypersensitivity to dexamethasone, tobramycin or any excipients, in viral or fungal eye infections, and in individuals with uncontrolled ocular hypertension or glaucoma unless closely monitored by an eye specialist.